EEF1A2 FOR USE IN THE PROGNOSIS, DIAGNOSIS AND TREATMENT OF CANCER

Details for Australian Patent Application No. 2003240326 (hide)

Owner CANCER CARE ONTARIO

Inventors LEE, Jonathan, M.

Pub. Number AU-A-2003240326

PCT Number PCT/CA03/00865

PCT Pub. Number WO2003/104488

Priority 60/387,231 07.06.02 US

Filing date 6 June 2003

Wipo publication date 22 December 2003

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 60/387,231 07.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2003240326

24 February 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240327-COMPOSITION AND METHODS FOR OBTAINING NUCLEIC ACIDS FROM SPUTUM

2003240325-OPTICAL CHANNEL MONITORING INTEGRATED IN A DEMULTIPLEXER